Patents by Inventor Boris Boumajny

Boris Boumajny has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190339236
    Abstract: In one aspect, the disclosure provides methods of distinguishing a glycosaminoglycan from one or more other components in a sample by subjecting the sample to size-exclusion chromatography using a mobile phase having a pH of 6.8 or lower. A mobile phase having a pH of 6.8 or lower is found to improve the separation of glycosaminoglycans from proteins during size exclusion chromatography. In some embodiments, improved separation is due to the low pH of the mobile phase causing elution of less dispersed fractions of the protein and/or glycosaminoglycan. In some embodiments, the overlap between protein and/or glycosaminoglycan fractions is reduced.
    Type: Application
    Filed: April 16, 2019
    Publication date: November 7, 2019
    Inventors: Zoran SOSIC, Andrew BLUM, Bing GUAN, Boris BOUMAJNY
  • Patent number: 10317376
    Abstract: In one aspect, the disclosure provides methods of distinguishing a glycosaminoglycan from one or more other components in a sample by subjecting the sample to size-exclusion chromatography using a mobile phase having a pH of 6.8 or lower. A mobile phase having a pH of 6.8 or lower is found to improve the separation of glycosaminoglycans from proteins during size exclusion chromatography. In some embodiments, improved separation is due to the low pH of the mobile phase causing elution of less dispersed fractions of the protein and/or glycosaminoglycan. In some embodiments, the overlap between protein and/or glycosaminoglycan fractions is reduced.
    Type: Grant
    Filed: April 11, 2013
    Date of Patent: June 11, 2019
    Assignee: Bioverativ Therapeutics Inc.
    Inventors: Zoran Sosic, Andrew Blum, Bing Guan, Boris Boumajny
  • Publication number: 20150075261
    Abstract: In one aspect, the disclosure provides methods of distinguishing a glycosaminoglycan from one or more other components in a sample by subjecting the sample to size-exclusion chromatography using a mobile phase having a pH of 6.8 or lower. A mobile phase having a pH of 6.8 or lower is found to improve the separation of glycosaminoglycans from proteins during size exclusion chromatography. In some embodiments, improved separation is due to the low pH of the mobile phase causing elution of less dispersed fractions of the protein and/or glycosaminoglycan. In some embodiments, the overlap between protein and/or glycosaminoglycan fractions is reduced.
    Type: Application
    Filed: April 11, 2013
    Publication date: March 19, 2015
    Applicant: Biogen Idec MA Inc.
    Inventors: Zoran Sosic, Andrew Blum, Bing Guan, Boris Boumajny